Affiliation:
1. Ahvaz Jundishapur University of Medical Sciences
2. Technical and Vocational University (TVU)
3. Imam Khomeini Hospital, Ahvaz Jundishapur University of Medical Sciences
Abstract
Abstract
Introduction
IBS manifestations are similar to heartburn, making diagnosis difficult for physicians. To diagnose this illness, doctors now rely on their experiences and therapeutic guidelines. Misdiagnosis, added costs, and extended treatment times are possible outcomes of this method. Researchers believe CDSS can help clinicians solve problems when used to make decisions. The CDSS is used in this current study to diagnose IBS.
Methods
The fuzzy-logic algorithm was optimized in this applicable modeling research using particle swarm optimization (PSO). Input data, an inference engine, and output data comprised this fuzzy-logic model-based system. Classification algorithms and the PSO method were used to select the input variables. PSO and "If-then" rules were used in the inference engine to extract data from the dataset. Patients experiencing IBS and normal people make up the output. The accuracy, sensitivity, precision, specificity, confusion Matrix, kappa test, and F-measure values of this model were used to assess its performance.
Results
The recommended model had a mean score of 96.5% accuracy, 100% sensitivity, 95.2% precision, and 89.4% specificity.
Conclusion
The optimized model was found that effectively diagnosed IBS cases. To improve the accuracy of this disease's diagnosis, healthcare organizations can implement the aforementioned model into their strategic scheduling at a reasonable expense.
Publisher
Research Square Platform LLC
Reference31 articles.
1. Irritable bowel syndrome: the clinical approach;Adriani A;Panminerva Med,2018
2. Global burden of irritable bowel syndrome: trends, predictions and risk factors;Black CJ;Nature Reviews Gastroenterology & Hepatology,2020
3. The overlap between irritable bowel syndrome and organic gastrointestinal diseases;Aziz I;The Lancet Gastroenterology & Hepatology,2021
4. Costs of irritable bowel syndrome in European countries with universal healthcare coverage: a meta-analysis;Flacco ME;Eur Rev Med Pharmacol Sci,2019
5. Quality of life in patients with irritable bowel syndrome;Mönnikes H;J Clin Gastroenterol,2011